introduction/brief CV
Dr. Abdul Ahad working as a Professor at Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He has published more than hundred high quality research and review articles in several peer-reviewed journals of international repute.
As per Google Scholar his publications received 5872 citations and his h-index is 45, i10-index 104 (accessed on 08 Jan 2025). He has been listed among the world's top 2% Scientist List 2023, 2022, 2021, 2020 and 2019, prepared by the Stanford University, USA.
Dr. Abdul Ahad has two patents 1) “A novel formulation to transdermally deliver antihypertensive agent with permeability enhancer”, patent number 277571, granted on 24/11/2016 and 2) “alpha-terpinene as a novel permeation enhancer”, patent number 382589, granted on 25/11/2021.
He is on Editorial Board of high ranked peer-reviewed Scientific journals like Pharmaceutics, Scientific reports, Biomed research international and Current Drug Delivery.
His current research interest lies in lipid based nanomedicine formulations development for oral/dermal/transdermal drug delivery.
For more information about Dr. Abdul Ahad, see his webpage at https://scholar.google.com/citations?hl=en&user=qKsiOo0AAAAJ as well as visit his ResearchID at http://www.researcherid.com/rid/L-8383-2015.